European Archives - Page 14 of 1192 - European Medical Journal

NHS Expands Access to Once-Daily Cystic Fibrosis Treatment

Hundreds of people with cystic fibrosis in England will now have access to a new once-daily triple therapy, expanding treatment to rare genetic types for the first time.

Peripheral Vision Training Improves Radiology Accuracy and Speed

Learn how visual training improves radiology accuracy and efficiency, with peripheral focus proving more impactful than central vision methods.

Hybrid Tumour-Immune Cells Found in Blood of Patients with Breast Cancer

Scientists have identified a rare and previously overlooked type of circulating tumour cell (CTC) in patients with metastatic breast cancer…

A colourful flat illustration of a woman in a lab coat looking down at a pestle and mortar, plants, pills and tinctures

Pharma’s role in the rise of wellness misinformation

Wellness trends are outpacing science and endangering lives. As trust in traditional medicine erodes, pharma must step in to correct the narrative.

Dapagliflozin Reverses Cardiac Fibrosis in Diabetic HFpEF, Study Finds

Dapagliflozin reverses myocardial fibrosis in HFpEF with diabetes, suggesting a disease-modifying effect.

Gut Microbiome Predicts Success of Peanut Immunotherapy

Peanut oral immunotherapy (POIT), which involves gradually increasing exposure to peanut protein, has shown promise, successfully desensitising 50–70% of patients.

EAN 2025 Interview: Jana Midelfart-Hoff

The most rewarding aspect is definitely the people you meet on the board. There are so many enthusiastic and extremely competent colleagues…

LHRH Antagonists in Prostate Cancer

Androgen deprivation therapy (ADT) has long been a foundation in the management of prostate cancer. Since the introduction of gonadotropin…

Subclinical Liver Fibrosis Linked to Cardiac Death Risk

Discover a study revealing how subclinical liver fibrosis, measured by FIB-4, predicts increased mortality risk in coronary artery disease patients.

Dr Daejin Adiboye

AbbVie's Dr Daejin Abidoye on community and compassion in cancer care

AbbVie’s Daejin Abidoye reflects on his 20-year journey in oncology – from clinical insights to advances in precision medicine in the cancer space.